Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Rathod

Showing results (221-230 of 235) with videos related to

Pageof 24
Sort By:
Mbio|May 2, 2019
Meta-analysis of Plasmodium falciparum <i>var</i> Signatures Contributing to Severe Malaria in African Children and Indian AdultsFergal Duffy, Maria Bernabeu, Prasad H Babar, et al.
Antimicrobial Agents and Chemotherapy|July 24, 2019
Decreased <i>In Vitro</i> Artemisinin Sensitivity of <i>Plasmodium falciparum</i> across IndiaRimi Chakrabarti, John White, Prasad H Babar, et al.
ACS Omega|September 11, 2018
Isoxazolopyrimidine-Based Inhibitors of Sreekanth Kokkonda, Farah El Mazouni, Karen L White, et al.
ACS Infectious Diseases|November 24, 2015
Diaza-anthracene Antibiotics from a Freshwater-Derived Actinomycete with Selective Antibacterial Activity toward <i>Mycobacterium tuberculosis</i>Michael W Mullowney, Chang Hwa Hwang, Andrew G Newsome, et al.
Acta Tropica|January 18, 2012
Malaria in South Asia: prevalence and controlAshwani Kumar, Laura Chery, Chinmoy Biswas, et al.
Journal of Molecular Biology|January 15, 2010
The crystal structure and activity of a putative trypanosomal nucleoside phosphorylase reveal it to be a homodimeric uridine phosphorylaseEric T Larson, Devaraja G Mudeppa, J Robert Gillespie, et al.
Journal of Medicinal Chemistry|June 24, 2011
Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potentialJose M Coteron, María Marco, Jorge Esquivias, et al.
Journal of Medicinal Chemistry|April 30, 2016
Tetrahydro-2-naphthyl and 2-Indanyl Triazolopyrimidines Targeting Plasmodium falciparum Dihydroorotate Dehydrogenase Display Potent and Selective Antimalarial ActivitySreekanth Kokkonda, Xiaoyi Deng, Karen L White, et al.
Journal of Medicinal Chemistry|April 7, 2020
Lead Optimization of a Pyrrole-Based Dihydroorotate Dehydrogenase Inhibitor Series for the Treatment of MalariaSreekanth Kokkonda, Xiaoyi Deng, Karen L White, et al.
ACS Infectious Diseases|September 20, 2016
A Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Improved Drug-like Properties for Treatment and Prevention of MalariaMargaret A Phillips, Karen L White, Sreekanth Kokkonda, et al.
Pageof 24

Showing results (221-230 of 235) with videos related to

Sort By:
Pageof 24
Mbio|May 2, 2019
Meta-analysis of Plasmodium falciparum <i>var</i> Signatures Contributing to Severe Malaria in African Children and Indian AdultsFergal Duffy, Maria Bernabeu, Prasad H Babar, et al.
Antimicrobial Agents and Chemotherapy|July 24, 2019
Decreased <i>In Vitro</i> Artemisinin Sensitivity of <i>Plasmodium falciparum</i> across IndiaRimi Chakrabarti, John White, Prasad H Babar, et al.
ACS Omega|September 11, 2018
Isoxazolopyrimidine-Based Inhibitors of Sreekanth Kokkonda, Farah El Mazouni, Karen L White, et al.
ACS Infectious Diseases|November 24, 2015
Diaza-anthracene Antibiotics from a Freshwater-Derived Actinomycete with Selective Antibacterial Activity toward <i>Mycobacterium tuberculosis</i>Michael W Mullowney, Chang Hwa Hwang, Andrew G Newsome, et al.
Acta Tropica|January 18, 2012
Malaria in South Asia: prevalence and controlAshwani Kumar, Laura Chery, Chinmoy Biswas, et al.
Journal of Molecular Biology|January 15, 2010
The crystal structure and activity of a putative trypanosomal nucleoside phosphorylase reveal it to be a homodimeric uridine phosphorylaseEric T Larson, Devaraja G Mudeppa, J Robert Gillespie, et al.
Journal of Medicinal Chemistry|June 24, 2011
Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potentialJose M Coteron, María Marco, Jorge Esquivias, et al.
Journal of Medicinal Chemistry|April 30, 2016
Tetrahydro-2-naphthyl and 2-Indanyl Triazolopyrimidines Targeting Plasmodium falciparum Dihydroorotate Dehydrogenase Display Potent and Selective Antimalarial ActivitySreekanth Kokkonda, Xiaoyi Deng, Karen L White, et al.
Journal of Medicinal Chemistry|April 7, 2020
Lead Optimization of a Pyrrole-Based Dihydroorotate Dehydrogenase Inhibitor Series for the Treatment of MalariaSreekanth Kokkonda, Xiaoyi Deng, Karen L White, et al.
ACS Infectious Diseases|September 20, 2016
A Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Improved Drug-like Properties for Treatment and Prevention of MalariaMargaret A Phillips, Karen L White, Sreekanth Kokkonda, et al.
Pageof 24